This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Mauricio Rocha-e-Silva: Innovator in Hypertonic Resuscitation Fluids
Introduction
Mauricio Rocha-e-Silva is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of medical formulations, particularly in the area of resuscitation fluids. His work focuses on improving treatment methods for patients experiencing hemorrhagic shock.
Latest Patents
One of Rocha-e-Silva's key patents is titled "Hypertonic isochloremic formulations for treatment of hypovolemic." This invention relates to hypertonic crystalloid resuscitation fluids that are particularly useful in treating hemorrhagic shock. The pharmaceutical formulation consists of selected ratios of sodium chloride and sodium acetate, with a total osmolar concentration exceeding 500 mOsm. This formulation can be utilized as a small volume resuscitation fluid that minimally affects plasma chloride levels. The invention aims to improve arterial pressure, thereby sustaining oxygen supply to tissues and organs, which results in a significant increase in oxygen delivery and consumption.
Career Highlights
Mauricio Rocha-e-Silva is affiliated with the University of Texas System, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on emergency medicine and patient care.
Collaborations
Rocha-e-Silva has collaborated with esteemed colleagues, including George C. Kramer and Irineu T. Velasco. These partnerships have contributed to the development and refinement of his innovative formulations.
Conclusion
Mauricio Rocha-e-Silva's contributions to the field of medical formulations, particularly in hypertonic resuscitation fluids, highlight his commitment to improving patient outcomes in critical situations. His innovative work continues to pave the way for advancements in medical treatment.